Economic Impact of Lyme Disease

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Zhang, Xinzhi ; Meltzer, Martin I. ; Peña, César A. ; Hopkins, Annette B. ; Wroth, Lane ; Fix, Alan D.
• Description:
  To assess the economic impact of Lyme disease (LD), the most common vectorborne inflammatory disease in the United States, cost data were collected in 5 counties of the Maryland Eastern Shore from 1997 to 2000. Patients were divided into 5 diagnosis groups, clinically defined early-stage LD, clinically defined late-stage LD, suspected LD, tick bite, and other related complaints. From 1997 to 2000, the mean per patient direct medical cost of early-stage LD decreased from $1,609 to $464 (p<0.05), and the mean per patient direct medical cost of late-stage LD decreased from $4,240 to $1,380 (p<0.05). The expected median of all costs (direct medical cost, indirect medical cost, nonmedical cost, and productivity loss), aggregated across all diagnosis groups of patients, was approximately $281 per patient. These findings will help assess the economics of current and future prevention and control efforts.
• Subjects:
  • Aging
  • Data Collection
  • Health Care Costs
  • Hospitalization
  • Humans
  • Lyme Disease
  • Multivariate Analysis
  • Questionnaires
  • Time Factors
• Source:
  Emerg Infect Dis. 12(4):653-660.
• Document Type:
  Journal Article
• Place as Subject:
  Maryland
• Volume:
  12
• Issue:
  4
• Download URL:
  https://stacks.cdc.gov/view/cdc/7884/cdc_7884_DS1.pdf
• File Type:
  [PDF - 325.69 KB]
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:d741c2f17a102ec2e3a16b0e22f8347d08b0c1e8b266441b763df87aaa098648